{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["COVID-19", "Cytokine storm", "Inflammation", "SARS-CoV-2", "Statins"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37378783", "DateCompleted": {"Year": "2023", "Month": "06", "Day": "30"}, "DateRevised": {"Year": "2023", "Month": "06", "Day": "30"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.1007/978-3-031-28012-2_25"], "Journal": {"ISSN": "0065-2598", "JournalIssue": {"Volume": "1412", "PubDate": {"Year": "2023"}}, "Title": "Advances in experimental medicine and biology", "ISOAbbreviation": "Adv Exp Med Biol"}, "ArticleTitle": "Statins: Beneficial Effects in Treatment of COVID-19.", "Pagination": {"StartPage": "457", "EndPage": "476", "MedlinePgn": "457-476"}, "Abstract": {"AbstractText": ["The recent viral disease COVID-19 has attracted much attention. The disease is caused by SARS-CoV-19 virus which has different variants and mutations. The mortality rate of SARS-CoV-19 is high and efforts to establish proper therapeutic solutions are still ongoing. Inflammation plays a substantial part in the pathogenesis of this disease causing mainly lung tissue destruction and eventually death. Therefore, anti-inflammatory drugs or treatments that can inhibit inflammation are important options. Various inflammatory pathways such as nuclear factor Kappa B (NF-\u03baB), signal transducer of activators of transcription (STAT), nod-like receptor family protein 3 (NLRP), toll-like receptors (TLRs), mitogen-activated protein kinase (MAPK), and mammalian target of rapamycin (mTOR) pathways and mediators, such as interleukin (IL)-6, IL-1\u03b2, tumor necrosis factor-\u03b1 (TNF-\u03b1), and interferon-\u03b3 (INF-\u03b3), cause cell apoptosis, reduce respiratory capacity and oxygen supply, eventually inducing respiratory system failure and death. Statins are well known for controlling hypercholesterolemia and may serve to treat COVID-19 due to their pleiotropic effects among which are anti-inflammatory in nature. In this chapter, the anti-inflammatory effects of statins and their possible beneficial effects in COVID-19 treatment are discussed. Data were collected from experimental and clinical studies in English (1998-October 2022) from Google Scholar, PubMed, Scopus, and the Cochrane Library."], "CopyrightInformation": "\u00a9 2023. The Author(s), under exclusive license to Springer Nature Switzerland AG."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Toxicology & Pharmacology, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran."}, {"Identifier": [], "Affiliation": "GI Pharmacology Interest Group (GPIG), Universal Scientific Education and Research Network (USERN), Tehran, Iran."}], "LastName": "Lashgari", "ForeName": "Naser-Aldin", "Initials": "NA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Toxicology & Pharmacology, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran."}, {"Identifier": [], "Affiliation": "GI Pharmacology Interest Group (GPIG), Universal Scientific Education and Research Network (USERN), Tehran, Iran."}], "LastName": "Roudsari", "ForeName": "Nazanin Momeni", "Initials": "NM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Toxicology & Pharmacology, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran."}, {"Identifier": [], "Affiliation": "GI Pharmacology Interest Group (GPIG), Universal Scientific Education and Research Network (USERN), Tehran, Iran."}], "LastName": "Shamsnia", "ForeName": "Hedieh", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran."}, {"Identifier": [], "Affiliation": "Experimental Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Shayan", "ForeName": "Maryam", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "GI Pharmacology Interest Group (GPIG), Universal Scientific Education and Research Network (USERN), Tehran, Iran."}, {"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran."}, {"Identifier": [], "Affiliation": "Toxicology and Diseases Group (TDG), Pharmaceutical Sciences Research Center (PSRC), The Institute of Pharmaceutical Sciences (TIPS), and Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Momtaz", "ForeName": "Saeideh", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Toxicology & Pharmacology, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran."}, {"Identifier": [], "Affiliation": "GI Pharmacology Interest Group (GPIG), Universal Scientific Education and Research Network (USERN), Tehran, Iran."}], "LastName": "Abdolghaffari", "ForeName": "Amir Hossein", "Initials": "AH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Matbou Riahi", "ForeName": "Maryam", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Jamialahmadi", "ForeName": "Tannaz", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Neuroproteomics, Department of Biochemistry and Tissue Biology, Institute of Biology, University of Campinas (UNICAMP), Campinas, Brazil."}, {"Identifier": [], "Affiliation": "Department of Psychiatry, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany."}, {"Identifier": [], "Affiliation": "Laboratory of Translational Psychiatry, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany."}], "LastName": "Guest", "ForeName": "Paul C", "Initials": "PC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "University Hospital Center Zagreb, Zagreb, Croatia."}], "LastName": "Reiner", "ForeName": "\u017deljko", "Initials": "\u017d"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran."}, {"Identifier": [], "Affiliation": "Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran."}, {"Identifier": [], "Affiliation": "Department of Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Sahebkar", "ForeName": "Amirhossein", "Initials": "A"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Adv Exp Med Biol", "NlmUniqueID": "0121103", "ISSNLinking": "0065-2598"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Hydroxymethylglutaryl-CoA Reductase Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Interleukin-6"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "COVID-19"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Hydroxymethylglutaryl-CoA Reductase Inhibitors"}, {"QualifierName": [], "DescriptorName": "COVID-19 Drug Treatment"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Inflammation"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": [], "DescriptorName": "Interleukin-6"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Saengsiwaritt W, Jittikoon J, Chaikledkaew U, et al (2022) Genetic polymorphisms of ACE1, ACE2, and TMPRSS2 associated with COVID-19 severity: A systematic review with meta-analysis. Rev Med Virol 32(4):e2323. https://doi.org/10.1002/rmv.2323", "ArticleIdList": ["10.1002/rmv.2323", "34997794"]}, {"Citation": "Pearce L, Davidson SM, Yellon DM (2020) The cytokine storm of COVID-19: a spotlight on prevention and protection. Expert Opin Ther Targets 24(8):723\u2013730", "ArticleIdList": ["32594778", "10.1080/14728222.2020.1783243"]}, {"Citation": "Altable M, de la Serna JM (2021) Protection against COVID-19 in African population: Immunology, genetics, and malaria clues for therapeutic targets. Virus Res 299:198347. https://doi.org/10.1016/j.virusres", "ArticleIdList": ["10.1016/j.virusres", "33631219"]}, {"Citation": "Datta C, Bhattacharjee A (2020) Cytokine Storm and its Implication in Coronavirus disease 2019 (COVID-19). J Immunol Sci 4(3). https://doi.org/10.1002/jmv.26232"}, {"Citation": "Cascella M, Rajnik M, Aleem A, et al (2022) Features, evaluation, and treatment of coronavirus (COVID-19). In: StatPearls [Internet]; StatPearls Publishing; Treasure Island, FL, USA)"}, {"Citation": "Azmi NU, Puteri MU, Lukmanto D (2020) Cytokine storm in COVID-19: An overview, mechanism, treatment strategies, and stem cell therapy perspective. Pharm Sci Res 7(1). https://doi.org/10.7454/psr.v7i4.1092"}, {"Citation": "Daniels LB, Kumar K (2022) The role of statin therapy in COVID-19. Expert Rev Cardiovasc Ther 20(6):415\u2013417", "ArticleIdList": ["35608055", "10.1080/14779072.2022.2081548"]}, {"Citation": "Khalifeh M, Penson PE, Banach M, et al (2021) Statins as anti-pyroptotic agents. Arch Med Sci 17(5):1414\u20131417", "ArticleIdList": ["34522271", "8425236", "10.5114/aoms/141155"]}, {"Citation": "Sahebkar A, Serban C, Mikhailidis DP, et al (2015) Association between statin use and plasma d-dimer levels: A systematic review and meta-analysis of randomised controlled trials. J Thromb Haemost 114(3):546\u2013557"}, {"Citation": "Serban C, Sahebkar A, Ursoniu S, et al (2015) A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations. Sci Rep 5:9902. https://doi.org/10.1038/srep09902", "ArticleIdList": ["10.1038/srep09902", "25970700", "4429557"]}, {"Citation": "Sohrevardi SM, Nasab FS, Mirjalili MR, et al (2021) Effect of atorvastatin on delirium status of patients in the intensive care unit: A randomized controlled trial. Arch Med Sci 17(5):1423. https://doi.org/10.5114/aoms.2019.89330", "ArticleIdList": ["10.5114/aoms.2019.89330", "34522273"]}, {"Citation": "Bahrami A, Bo S, Jamialahmadi T, et al (2020) Effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on ageing: Molecular mechanisms. Ageing Res Rev 58:101024. https://doi.org/10.1016/j.arr.2020.101024", "ArticleIdList": ["10.1016/j.arr.2020.101024", "32006687"]}, {"Citation": "Bland AR, Payne FM, Ashton JC, et al (2022) The cardioprotective actions of statins in targeting mitochondrial dysfunction associated with myocardial ischaemia-reperfusion injury. J Pharm Res 175:105986. https://doi.org/10.1016/j.phrs.2021.105986 .", "ArticleIdList": ["10.1016/j.phrs.2021.105986"]}, {"Citation": "Dehnavi S, Kiani A, Sadeghi M, et al (2021) Targeting AMPK by Statins: A Potential Therapeutic Approach. Drugs 81(8):923\u2013933", "ArticleIdList": ["33939118", "8144155", "10.1007/s40265-021-01510-4"]}, {"Citation": "Gorabi AM, Kiaie N, Bianconi V, et al (2021) Statins Attenuate Fibrotic Manifestations of Cardiac Tissue Damage. Curr Mol Pharmacol 14(5):782\u2013797", "ArticleIdList": ["33568040", "10.2174/1874467214666210210123206"]}, {"Citation": "Hosseini A, Sahranavard T, Reiner \u017d, et al (2022) Effect of statins on abdominal aortic aneurysm. Eur J Pharm Sci 178:106284. https://doi.org/10.1016/j.ejps.2022.106284 .", "ArticleIdList": ["10.1016/j.ejps.2022.106284", "36038100"]}, {"Citation": "Kouhpeikar H, Delbari Z, Sathyapalan T, et al (2020) The Effect of Statins through Mast Cells in the Pathophysiology of Atherosclerosis: a Review. Curr Atheroscler Rep 22(5):19. https://doi.org/10.1007/s11883-020-00837-9", "ArticleIdList": ["10.1007/s11883-020-00837-9", "32458165"]}, {"Citation": "Fehr, A.R., Perlman, S. (2015) Coronaviruses: An Overview of their Replication and Pathogenesis. Methods Mol Biol 1282:1\u201323", "ArticleIdList": ["25720466", "4369385", "10.1007/978-1-4939-2438-7_1"]}, {"Citation": "Woo PCY, Huang Y, Lau SKP, et al (2010) Coronavirus genomics and bioinformatics analysis. Viruses 2(8):1804\u20131820", "ArticleIdList": ["21994708", "3185738", "10.3390/v2081803"]}, {"Citation": "Chathappady House NN, Palissery S, Sebastian H (2021) Corona Viruses: A Review on SARS, MERS and COVID-19. Microbiol Insights 14:11786361211002481. https://doi.org/10.4103/jfmpc.jfmpc_839_21 .", "ArticleIdList": ["10.4103/jfmpc.jfmpc_839_21", "33795938", "7983408"]}, {"Citation": "Cherry J, Demmler-Harrison GJ, Kaplan SL, et al (2018) Feigin and Cherry\u2019s Textbook of Pediatric Infectious Diseases. Elsevier Health Sciences; Amsterdam, Netherlands. ISBN-13: 0323376921-978"}, {"Citation": "Snijder EJ, Bredenbeek PJ, Dobbe JC, et al (2003) Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J Mol Biol 331(5):991\u20131004", "ArticleIdList": ["12927536", "7159028", "10.1016/S0022-2836(03)00865-9"]}, {"Citation": "Neuman BW, Kiss G, Kunding AH, et al (2011) A structural analysis of M protein in coronavirus assembly and morphology. J Struct Biol 174(1):11\u201322", "ArticleIdList": ["21130884", "10.1016/j.jsb.2010.11.021"]}, {"Citation": "Cruz CAK, Medina PMB (2021) Diversity in the Accessory Proteins of SARS-CoV-2, SARS-CoV, and MERS-CoV Betacoronaviruses. Curr Protein Pept Sci 22(10):695\u2013715", "ArticleIdList": ["34514989", "10.2174/1389203722666210910111055"]}, {"Citation": "Rastogi M, Pandey N, Shukla A, et al (2020) SARS coronavirus 2: from genome to infectome. Respir Res 21(1):318. https://doi.org/10.1186/s12931-020-01581-z .", "ArticleIdList": ["10.1186/s12931-020-01581-z", "33261606", "7706175"]}, {"Citation": "Tortorici MA, Veesler D (2019) Structural insights into coronavirus entry. Adv Virus Res 105:93\u2013116", "ArticleIdList": ["31522710", "7112261", "10.1016/bs.aivir.2019.08.002"]}, {"Citation": "Zhu Z, Lian X, Su X, et al (2020) From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses. Respir Res 21(1):224. https://doi.org/10.1186/s12931-020-01479-w", "ArticleIdList": ["10.1186/s12931-020-01479-w", "32854739", "7450684"]}, {"Citation": "Samukawa K (1982) [Use of stable isotopes in life science (III). Measurement of 15N abundance in amino acids with gas chromatography-mass spectrometry (author\u2019s transl)]. Radioisotopes 31(3):166\u2013174", "ArticleIdList": ["7100515", "10.3769/radioisotopes.31.3_166"]}, {"Citation": "Dooley DC (1982) Glycerol permeation of the human granulocyte. Exp Hematol 10(5):413\u2013422", "ArticleIdList": ["7095016"]}, {"Citation": "Lu G, Hu Y, Wang Q, et al (2013) Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26. Nature 500(7461):227\u2013231", "ArticleIdList": ["23831647", "7095341", "10.1038/nature12328"]}, {"Citation": "Sender R, Bar-On YM, Gleizer S, et al (2021) The total number and mass of SARS-CoV-2 virions. Proc Natl Acad Sci 118(25):e2024815118. https://doi.org/10.1073/pnas.2024815118", "ArticleIdList": ["10.1073/pnas.2024815118", "34083352", "8237675"]}, {"Citation": "Goldsmith CS, Tatti KM, Ksiazek TG, et al (2004) Ultrastructural characterization of SARS coronavirus. Emerg Infect Dis 10(2):320\u2013326", "ArticleIdList": ["15030705", "3322934", "10.3201/eid1002.030913"]}, {"Citation": "Kumar S, Nyodu R, Maurya VK, et al. Morphology, Genome Organization, Replication, and Pathogenesis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Coronavirus Disease 2019 (COVID-19):23\u201331. https://doi.org/10.1007/978-981-15-4814-7_3", "ArticleIdList": ["10.1007/978-981-15-4814-7_3"]}, {"Citation": "Ke Z, Oton J, Qu K, et al (2020) Structures and distributions of SARS-CoV-2 spike proteins on intact virions. Nature 588(7838):498\u2013502", "ArticleIdList": ["32805734", "7116492", "10.1038/s41586-020-2665-2"]}, {"Citation": "Hurdiss DL, Drulyte I, Lang Y, et al (2020) Cryo-EM structure of coronavirus-HKU1 haemagglutinin esterase reveals architectural changes arising from prolonged circulation in humans. Nat Commun 11(1):4646. https://doi.org/10.1038/s41467-020-18440-6", "ArticleIdList": ["10.1038/s41467-020-18440-6", "32938911", "7495468"]}, {"Citation": "Mandala VS, McKay MJ, Shcherbakov AA, et al (2020) Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers. Nat Struct Mol Biol 27(12):1202\u20131208", "ArticleIdList": ["33177698", "7718435", "10.1038/s41594-020-00536-8"]}, {"Citation": "Hu Y, Wen J, Tang L, et al (2003) The M protein of SARS-CoV: basic structural and immunological properties. Genomics Proteomics Bioinformatics 1(2):118\u2013130", "ArticleIdList": ["15626342", "5172243", "10.1016/S1672-0229(03)01016-7"]}, {"Citation": "Lissenberg A, Vrolijk MM, van Vliet AL, et al (2005) Luxury at a cost? Recombinant mouse hepatitis viruses expressing the accessory haemagglutinin esterase protein display reduced fitness in vitro. J Virol 79(24):15054\u201315063", "ArticleIdList": ["16306576", "1316008", "10.1128/JVI.79.24.15054-15063.2005"]}, {"Citation": "Boopathi S, Poma AB, Kolandaivel P (2021) Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment. J Biomol Struct Dyn 39(9):3409\u20133418", "ArticleIdList": ["32306836"]}, {"Citation": "de Haan CAM, Volders H, Koetzner CA, et al (2002) Coronaviruses maintain viability despite dramatic rearrangements of the strictly conserved genome organization. J Virol 76(24):12491\u201312502.", "ArticleIdList": ["12438575", "136672", "10.1128/JVI.76.24.12491-12502.2002"]}, {"Citation": "Kandeel M, Ibrahim A, Fayez M, et al (2020) From SARS and MERS CoVs to SARS-CoV-2: Moving toward more biased codon usage in viral structural and nonstructural genes. J Med Virol 92(6):660\u2013666", "ArticleIdList": ["32159237", "7228358", "10.1002/jmv.25754"]}, {"Citation": "Gorkhali R, Koirala P, Rijal S, et al (2021) Structure and Function of Major SARS-CoV-2 and SARS-CoV Proteins. Bioinform Biol 15:11779322211025876. https://doi.org/10.1177/11779322211025876 .", "ArticleIdList": ["10.1177/11779322211025876"]}, {"Citation": "Romano M, Ruggiero A, Squeglia F, et al (2020) A Structural View of SARS-CoV-2 RNA Replication Machinery: RNA Synthesis, Proofreading and Final Capping. Cells 9(5):1267. https://doi.org/10.3390/cells9051267 .", "ArticleIdList": ["10.3390/cells9051267", "32443810", "7291026"]}, {"Citation": "Shang J, Wan Y, Luo C, et al (2020) Cell entry mechanisms of SARS-CoV-2. Proc Natl Acad Sci USA 117(21):11727\u201311734", "ArticleIdList": ["32376634", "7260975", "10.1073/pnas.2003138117"]}, {"Citation": "van Hemert MJ, van den Worm SH, Knoops K, et al (2008) SARS-coronavirus replication/transcription complexes are membrane-protected and need a host factor for activity in vitro. PLoS Pathog 4(5):e1000054. https://doi.org/10.1371/journal.ppat.1000054 .", "ArticleIdList": ["10.1371/journal.ppat.1000054", "18451981", "2322833"]}, {"Citation": "Hu B, Guo H, Zhou P, et al (2021) Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol 19(3):141\u2013154", "ArticleIdList": ["33024307", "10.1038/s41579-020-00459-7"]}, {"Citation": "Fan Y, Zhao K, Shi ZL, et al (2019) Bat Coronaviruses in China. Viruses 11(3):210. https://doi.org/10.3390/v11030210 .", "ArticleIdList": ["10.3390/v11030210", "30832341", "6466186"]}, {"Citation": "Payne S. Family Coronaviridae. Viruses. 2017:149\u2013158. https://doi.org/10.1016/B978-0-12-803109-4.00017-9"}, {"Citation": "International Committee on Taxonomy of Viruses (ICTV). https://ictv.global/ . Accessed Oct 14, 2022"}, {"Citation": "Corman VM, Muth D, Niemeyer D, et al (2018) Hosts and Sources of Endemic Human Coronaviruses. Adv Virus Res 100:163\u2013188", "ArticleIdList": ["29551135", "7112090", "10.1016/bs.aivir.2018.01.001"]}, {"Citation": "Pal M, Berhanu G, Desalegn C, et al (2020) Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): An Update. Cureus 2(3):e7423. https://doi.org/10.7759/cureus.7423", "ArticleIdList": ["10.7759/cureus.7423"]}, {"Citation": "World Health Organization; Tracking SARS-CoV-2 variants. https://www.who.int/activities/tracking-SARS-CoV-2-variants . Accessed October 24, 2022"}, {"Citation": "Konings F, Perkins MD, Kuhn JH, et al (2021) SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourse. Nat Rev Microbiol 6(7):821\u2013823", "ArticleIdList": ["10.1038/s41564-021-00932-w"]}, {"Citation": "Silhol F, Sarlon G, Deharo JC, et al (2020) Downregulation of ACE2 induces overstimulation of the renin-angiotensin system in COVID-19: should we block the renin-angiotensin system? Hypertens Res 43(8):854\u2013856", "ArticleIdList": ["32439915", "7242178", "10.1038/s41440-020-0476-3"]}, {"Citation": "Choudhary S, Sharma K, Silakari O (2021) The interplay between inflammatory pathways and COVID-19: A critical review on pathogenesis and therapeutic options. Microb Pathog 150:104673. https://doi.org/10.1016/j.micpath.2020.104673 .", "ArticleIdList": ["10.1016/j.micpath.2020.104673", "33278517"]}, {"Citation": "Farahani M, Niknam Z, Mohammadi Amirabad L, et al (2022) Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets. Biomed Pharmacother 145:112420. https://doi.org/10.1016/j.biopha.2021.112420 .", "ArticleIdList": ["10.1016/j.biopha.2021.112420", "34801852"]}, {"Citation": "Yarmohammadi A, Yarmohammadi M, Fakhri S, et al (2021) Targeting pivotal inflammatory pathways in COVID-19: A mechanistic review. Eur J Pharmacol 890:173620. https://doi.org/10.1016/j.ejphar.2020.173620 .", "ArticleIdList": ["10.1016/j.ejphar.2020.173620", "33038418"]}, {"Citation": "Vuorio A, Kuoppala J, Kovanen PT, et al (2019) Statins for children with familial hypercholesterolemia. Cochrane Database Syst Rev (11):CD006401. https://doi.org/10.1002/14651858.CD006401.pub5 .", "ArticleIdList": ["10.1002/14651858.CD006401.pub5"]}, {"Citation": "Toth PP, Banach M (2019) Statins: Then and Now. Methodist Debakey Cardiovasc J 15(1):23\u201331", "ArticleIdList": ["31049146", "6489607", "10.14797/mdcj-15-1-23"]}, {"Citation": "Istvan E (2003) Statin inhibition of HMG-CoA reductase: a 3-dimensional view. Atheroscler Suppl 4(1):3\u20138", "ArticleIdList": ["12714031", "10.1016/S1567-5688(03)00003-5"]}, {"Citation": "Grundy SM (1988) HMG-CoA reductase inhibitors for treatment of hypercholesterolemia. N Engl J Med 319(1):24\u201333", "ArticleIdList": ["3288867", "10.1056/NEJM198807073190105"]}, {"Citation": "Barrios-Gonz\u00e1lez J, Miranda RU (2005) Biotechnological production and applications of statins. Appl Microbiol Biotechnol 85(4):869\u2013883", "ArticleIdList": ["10.1007/s00253-009-2239-6"]}, {"Citation": "Schachter M (2005) Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update. Fundam Clin Pharmacol (1):117\u2013125", "ArticleIdList": ["10.1111/j.1472-8206.2004.00299.x"]}, {"Citation": "Desager JP, Horsmans Y (1996) Clinical pharmacokinetics of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. Clin Pharmacokinet (5):348\u2013371", "ArticleIdList": ["10.2165/00003088-199631050-00003"]}, {"Citation": "Lennern\u00e4s H, Fager G (1997) Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences. Clin Pharmacokinet 32(5):403\u2013425", "ArticleIdList": ["9160173", "10.2165/00003088-199732050-00005"]}, {"Citation": "Bu DX, Griffin G, Lichtman AH (2011) Mechanisms for the anti-inflammatory effects of statins. Curr Opin Lipidol (3):165\u2013170", "ArticleIdList": ["10.1097/MOL.0b013e3283453e41"]}, {"Citation": "Davignon J, Jacob RF, Mason RP (2004) The antioxidant effects of statins. Coron Artery Dis (5):251\u2013258", "ArticleIdList": ["10.1097/01.mca.0000131573.31966.34"]}, {"Citation": "Parizadeh SMR, Azarpazhooh MR, Moohebati M, et al (2011) Simvastatin therapy reduces prooxidant-antioxidant balance: Results of a placebo-controlled cross-over trial. Lipids 46(4):333\u2013340", "ArticleIdList": ["21207250", "10.1007/s11745-010-3517-x"]}, {"Citation": "Antonopoulos AS, Margaritis M, Lee R, et al (2012) Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials. Curr Pharm Des 18(11):1519\u20131530", "ArticleIdList": ["22364136", "3394171", "10.2174/138161212799504803"]}, {"Citation": "Sikora J, Kostka B, Marczyk I, et al (2013) Effect of statins on platelet function in patients with hyperlipidemia. Arch Med Sci 9(4):622\u2013628", "ArticleIdList": ["24049520", "3776183", "10.5114/aoms.2013.36905"]}, {"Citation": "O\u2019Driscoll G, Green D, Taylor RR (2017) Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation 95(5):1126\u20131131", "ArticleIdList": ["10.1161/01.CIR.95.5.1126"]}, {"Citation": "Wang Q, Yan J, Chen X, et al (2011) Statins: multiple neuroprotective mechanisms in neurodegenerative diseases. Exp Neurol 230(1):27\u201334", "ArticleIdList": ["20406638", "10.1016/j.expneurol.2010.04.006"]}, {"Citation": "Golomb BA, Evans MA (2008) Statin adverse effects: a review of the literature and evidence for a mitochondrial mechanism. Am J Cardiovasc Drugs 8(6):373\u2013418", "ArticleIdList": ["19159124", "2849981", "10.2165/0129784-200808060-00004"]}, {"Citation": "Wierzbicki AS, Lumb PJ, Semra Y, Chik G, et al (1999) Atorvastatin compared with simvastatin-based therapies in the management of severe familial hyperlipidaemias. QJM 92(7):387\u201394.", "ArticleIdList": ["10627888", "10.1093/qjmed/92.7.387"]}, {"Citation": "Gotto Jr AMJC (2002) Statins: powerful drugs for lowering cholesterol: advice for patients. Am Heart J 105(13):1514\u20131516"}, {"Citation": "Liao JK, Laufs U (2005) Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol 45:89\u2013118", "ArticleIdList": ["15822172", "2694580", "10.1146/annurev.pharmtox.45.120403.095748"]}, {"Citation": "Blum A, Shamburek R (2009) The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis. Atherosclerosis 203(2):325\u2013330", "ArticleIdList": ["18834985", "10.1016/j.atherosclerosis.2008.08.022"]}, {"Citation": "Nissen SE, Nicholls SJ, Sipahi I, et al (2006) Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA 295(13):1556\u20131565", "ArticleIdList": ["16533939", "10.1001/jama.295.13.jpc60002"]}, {"Citation": "Ridker PM, Danielson E, Fonseca FA, et al (2008) Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359(21):2195\u20132207", "ArticleIdList": ["18997196", "10.1056/NEJMoa0807646"]}, {"Citation": "Kones R (2010) Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspective. Drug Des Devel Ther 4:383\u2013413", "ArticleIdList": ["21267417", "3023269", "10.2147/DDDT.S10812"]}, {"Citation": "Ascer E, Bertolami MC, Venturinelli ML, et al (2004) Atorvastatin reduces proinflammatory markers in hypercholesterolemic patients. Atherosclerosis 177(1):161\u2013166", "ArticleIdList": ["15488879", "10.1016/j.atherosclerosis.2004.07.003"]}, {"Citation": "van de Ree MA, Huisman MV, Princen HM, et al (2003) Strong decrease of high sensitivity C-reactive protein with high-dose atorvastatin in patients with type 2 diabetes mellitus. Atherosclerosis 166(1):129\u2013135", "ArticleIdList": ["12482559", "10.1016/S0021-9150(02)00316-7"]}, {"Citation": "Chansrichavala P, Chantharaksri U, Sritara P, et al (2009) Atorvastatin attenuates TLR4-mediated NF-kappaB activation in a MyD88-dependent pathway. Asian Pac J Allergy Immunol 27(1):49\u201357", "ArticleIdList": ["19548630"]}, {"Citation": "Spencer FA, Fonarow GC, Frederick PD, et al (2004) Early withdrawal of statin therapy in patients with non-ST-segment elevation myocardial infarction: national registry of myocardial infarction. Arch Intern Med 164(19):2162\u20132168", "ArticleIdList": ["15505131", "10.1001/archinte.164.19.2162"]}, {"Citation": "Heeschen C, Hamm CW, Laufs U, et al (2002) Withdrawal of statins increases event rates in patients with acute coronary syndromes. Circulation 105(12):1446\u20131452", "ArticleIdList": ["11914253", "10.1161/01.CIR.0000012530.68333.C8"]}, {"Citation": "DeDiego ML, Nieto-Torres J, Regla-Nava JA, et al (2013) Inhibition of NF- B-Mediated Inflammation in Severe Acute Respiratory Syndrome Coronavirus-Infected Mice Increases Survival. J Virol 88(2):913\u201324", "ArticleIdList": ["24198408", "10.1128/JVI.02576-13"]}, {"Citation": "Cimato TR, Palka BA (2015) Effects of statins on TH1 modulating cytokines in human subjects. PeerJ;3:e764. https://doi.org/10.7717/peerj.764 .", "ArticleIdList": ["10.7717/peerj.764", "25699211", "4327442"]}, {"Citation": "Yuan S (2015) Statins May Decrease the Fatality Rate of Middle East Respiratory Syndrome Infection. mBio 6(4):e01120. https://doi.org/10.1128/mBio.01120-15 .", "ArticleIdList": ["10.1128/mBio.01120-15", "26265720", "4542194"]}, {"Citation": "Jammal M, Riachy M, Haddad F (2022) Can statins be beneficial in Covid 19 patients? Int J Diabetes Clin Res 8:138. https://doi.org/10.23937/2377-3634/1410138", "ArticleIdList": ["10.23937/2377-3634/1410138"]}, {"Citation": "Reiner \u017d, Hatamipour M, Banach M, et al (2020) Statins and the Covid-19 main protease: In silico evidence on direct interaction. Arch Med Sci 16(2):490\u2013496", "ArticleIdList": ["32399094", "7212226", "10.5114/aoms.2020.94655"]}, {"Citation": "Vahedian-Azimi A, Mohammadi SM, Beni FH, et al (2021) Improved COVID-19 ICU admission and mortality outcomes following treatment with statins: A systematic review and meta-analysis. Arch Med Sci 17(3):579\u2013595", "ArticleIdList": ["34025827", "8130467", "10.5114/aoms/132950"]}, {"Citation": "Karampoor S, Hesamizadeh K, Shams Z, et al (2021) The role of lovastatin in the attenuation of COVID-19. Int Immunopharmacol 101(Pt A):108192. https://doi.org/10.1016/j.intimp.2021.108192", "ArticleIdList": ["10.1016/j.intimp.2021.108192", "34607230", "8461262"]}, {"Citation": "Vahedian-Azimi A, Mohammadi SM, Heidari Beni F, et al (2021) Improved COVID-19 ICU admission and mortality outcomes following treatment with statins: a systematic review and meta-analysis. Arch Med Sci 17(3):579\u201395", "ArticleIdList": ["34025827", "8130467", "10.5114/aoms/132950"]}, {"Citation": "Zapatero-Belinch\u00f3n FJ, Moeller R, Lasswitz L, et al (2021) Fluvastatin mitigates SARS-CoV-2 infection in human lung cells. iScience 24(12):103469. https://doi.org/10.1016/j.isci.2021.103469", "ArticleIdList": ["10.1016/j.isci.2021.103469", "34812415", "8599137"]}, {"Citation": "Rodriguez-Nava G, Trelles-Garcia DP, Yanez-Bello MA, et al (2020) Atorvastatin associated with decreased hazard for death in COVID-19 patients admitted to an ICU: a retrospective cohort study. Crit Care 24(1):429. https://doi.org/10.1186/s13054-020-03154-4 .", "ArticleIdList": ["10.1186/s13054-020-03154-4", "32664990", "7358561"]}, {"Citation": "Haji Aghajani M, Moradi O, Azhdari Tehrani H, et al (2021) Promising effects of atorvastatin on mortality and need for mechanical ventilation in patients with severe COVID-19; a retrospective cohort study. Int J Clin Pract 75(9):e14434. https://doi.org/10.1111/ijcp.14434", "ArticleIdList": ["10.1111/ijcp.14434", "34080261"]}, {"Citation": "Davoodi L, Jafarpour H, Oladi Z, et al (2021) Atorvastatin therapy in COVID-19 adult inpatients: A double-blind, randomized controlled trial. Int J Cardiol Heart Vasc 36:100875. https://doi.org/10.1016/j.ijcha.2021.100875", "ArticleIdList": ["10.1016/j.ijcha.2021.100875", "34541293", "8437805"]}, {"Citation": "INSPIRATION Investigators (2022) Atorvastatin versus placebo in patients with covid-19 in intensive care: randomized controlled trial. 2022;376. BMJ 376:e068407. https://doi.org/10.1136/bmj-2021-068407"}, {"Citation": "Ghafoori M, Saadati H, Taghavi M, et al (2022) Survival of the hospitalized patients with COVID-19 receiving atorvastatin: A randomized clinical trial. J Med Virol 94(7):3160\u20133168", "ArticleIdList": ["35274326", "9088596", "10.1002/jmv.27710"]}, {"Citation": "Reiner \u017d, Hatamipour M, Banach M, et al (2020) Statins and the COVID-19 main protease: in silico evidence on direct interaction. Arch Med Sci 16(3):490\u2013496", "ArticleIdList": ["32399094", "7212226", "10.5114/aoms.2020.94655"]}, {"Citation": "Sapey E, Patel JM, Greenwood HL, et al. Pulmonary Infections in the Elderly Lead to Impaired Neutrophil Targeting, Which Is Improved by Simvastatin. Am J Respir Crit Care Med 196(10):1325\u20131336"}, {"Citation": "Shrivastava-Ranjan P, Flint M, Bergeron \u00c9, et al (2018) Statins suppress Ebola virus infectivity by interfering with glycoprotein processing. mBio 9(3):e00660\u201318. https://doi.org/10.1128/mBio.00660-18", "ArticleIdList": ["10.1128/mBio.00660-18", "29717011", "5930306"]}, {"Citation": "Guo H, Huang M, Yuan Q, et al (2017) The Important Role of Lipid Raft-Mediated Attachment in the Infection of Cultured Cells by Coronavirus Infectious Bronchitis Virus Beaudette Strain. PLoS One;12(1):e0170123. https://doi.org/10.1371/journal.pone.0170123 .", "ArticleIdList": ["10.1371/journal.pone.0170123", "28081264", "5231368"]}, {"Citation": "Shakour N, Ruscica M, Hadizadeh F, et al (2020) Statins and C-reactive protein: In silico evidence on direct interaction. Arch Med Sci 16(6):1432\u20131439", "ArticleIdList": ["33224343", "7667423", "10.5114/aoms.2020.100304"]}, {"Citation": "Wang, H, Yang, P, Liu, K, et al (2008) SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway. Cell Res 18(2):290\u2013301", "ArticleIdList": ["18227861", "10.1038/cr.2008.15"]}, {"Citation": "INSPIRATION-S Investigators (2022) Atorvastatin versus placebo in patients with covid-19 in intensive care: randomized controlled trial. BMJ 376:e068407. https://doi.org/10.1136/bmj-2021-068407", "ArticleIdList": ["10.1136/bmj-2021-068407"]}, {"Citation": "Gait\u00e1n-Duarte HG, \u00c1lvarez-Moreno C, Rinc\u00f3n-Rodr\u00edguez CJ, et al (2021) Effectiveness of Rosuvastatin plus Colchicine, Emtricitabine/Tenofovir and a combination of them in Hospitalized Patients with SARS Covid-19. medRxiv https://doi.org/10.1101/2021.07.06.21260085"}, {"Citation": "Hayden MR (2020) An Immediate and Long-Term Complication of COVID-19 May Be Type 2 Diabetes Mellitus: The Central Role of beta-Cell Dysfunction, Apoptosis and Exploration of Possible Mechanisms. Cells 9(11). https://doi.org/10.3390/cells9112475"}, {"Citation": "Banach M, Penson PE, Fras Z, et al (2020) Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic. Pharmacol Res 158:104891. https://doi.org/10.1016/j.phrs.2020.104891", "ArticleIdList": ["10.1016/j.phrs.2020.104891", "32389859", "7204727"]}, {"Citation": "Couzin-Frankel J (2021) Antiviral pills could change pandemic\u2019s course. Science 374(6569):799\u2013800, https://doi.org/10.1126/science.acx9605", "ArticleIdList": ["10.1126/science.acx9605", "34762459"]}, {"Citation": "Menni C, Klaser K, May A, et al (2021) Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study. Lancet Infect Dis 21(7):939\u2013949", "ArticleIdList": ["33930320", "8078878", "10.1016/S1473-3099(21)00224-3"]}, {"Citation": "Teixeira L, Temerozo JR, Pereira-Dutra FS, et al (2022) Simvastatin Downregulates the SARS-CoV-2-Induced Inflammatory Response and Impairs Viral Infection Through Disruption of Lipid Rafts. Front Immunol 13:820131. https://doi.org/10.3389/fimmu.2022.820131", "ArticleIdList": ["10.3389/fimmu.2022.820131", "35251001", "8895251"]}, {"Citation": "Qian Y, Lei T, Patel PS, et al (2021) Direct Activation of Endothelial Cells by SARS-CoV-2 Nucleocapsid Protein Is Blocked by Simvastatin. J Virol 95(23):e0139621. https://doi.org/10.1128/JVI.01396-21 .", "ArticleIdList": ["10.1128/JVI.01396-21", "34549987"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "6", "Day": "30", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "6", "Day": "28", "Hour": "13", "Minute": "8"}, {"Year": "2023", "Month": "6", "Day": "28", "Hour": "11", "Minute": "7"}], "PublicationStatus": "ppublish", "ArticleIdList": ["37378783", "10.1007/978-3-031-28012-2_25"]}}], "PubmedBookArticle": []}